Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal.
Saved in:
| Title: | Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal. |
|---|---|
| Authors: | McMahon JH; Department of Infectious Diseases, Alfred Hospital and Monash University., Evans VA; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Lau JSY; Department of Infectious Diseases, Alfred Hospital and Monash University., Symons J; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Zerbato JM; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Chang J; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Solomon A; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Tennakoon S; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Dantanarayana A; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Hagenauer M; Department of Infectious Diseases, Alfred Hospital and Monash University., Lee S; University of California San Francisco, San Francisco, California, USA., Palmer S; The Westmead Institute for Medical Research, University of Sydney, Sydney, Westmead, Australia., Fisher K; The Westmead Institute for Medical Research, University of Sydney, Sydney, Westmead, Australia., Bumpus N; Johns Hopkins University, Baltimore, Maryland, USA., Heck CJS; Johns Hopkins University, Baltimore, Maryland, USA., Burger D; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands., Wu G; Department of Infectious Disease & Vaccine Research, Merck & Co., Inc., Kenilworth, New Jersey, USA., Zuck P; Department of Infectious Disease & Vaccine Research, Merck & Co., Inc., Kenilworth, New Jersey, USA., Howell BJ; Department of Infectious Disease & Vaccine Research, Merck & Co., Inc., Kenilworth, New Jersey, USA., Zetterberg HH; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square.; UK Dementia Research Institute at UCL, London, UK., Blennow K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden., Gisslen M; Department of Infectious Diseases at Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden., Rasmussen TA; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Lewin SR; Department of Infectious Diseases, Alfred Hospital and Monash University.; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria. |
| Source: | AIDS (London, England) [AIDS] 2022 Jan 01; Vol. 36 (1), pp. 75-82. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
